# Thornhill Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thornhill-medical

- Industry: Medical Devices & Equipment
- Headquarters: Toronto, Canada
- Website: www.thornhillmedical.com
- Latest round: Series A (Jul 19, 2018)
- Investors on record: 1

## About

Thornhill Medical is a Canadian company that develops advanced portable medical technologies, enhancing critical care delivery in difficult environments through innovative products designed for emergency and military use.Founded in 2003 and headquartered in Toronto, Canada, Thornhill Medical designs advanced medical technologies focused on portable critical care solutions. The company raised Series A funding in July 2018, led by Yonghua Capital, marking its strategic investment target. The current CEO is Lesley Gouldie.Thornhill Medical specializes in advanced portable medical technologies designed to enhance critical care delivery in challenging environments. Their flagship products, the MOVES® SLC™ and MADM™, provide integrated solutions for portable ventilation, oxygen delivery, vital signs monitoring, and anesthesia, particularly for combat casualty care, emergency medical services, and humanitarian efforts. The MOVES® SLC™ has been deployed as part of the US Navy’s En-Route Care System (ERCS) aboard the Eisenhower Strike Group, serving diverse markets such as military bases and emergency response units globally.Thornhill Medical generates revenue primarily through direct sales of its specialized medical devices, including the MOVES® SLC™ and MADM™, to healthcare providers and institutions. The sales often involve direct engagements with government entities, military contracts, and partnerships with international NGOs focused on emergency medical care. Pricing is aligned with the value of their advanced medical technology, fostering long-term relationships with clients that support continued innovation and service enhancements.Thornhill Medical plans to leverage its recent Series A funding, raised in July 2018, to further develop new products and expand into new markets. The company is focused on enhancing its product line, potentially launching additional innovations by 2025. Targeted geographic expansions include increased penetration into military and emergency response sectors across Europe and Asia, aiming to establish partnerships with local healthcare providers and NGOs. This strategic approach is expected to enhance their market reach and operational capacity.

## Funding rounds

- Series A, Jul 19, 2018 — Yonghua Capital

## Investors

- Yonghua Capital (https://capitalatlas.ai/funds/yonghua-capital) — Series A